Centenial Surgical Suture Limited
BSE: CSURGSU
Prev Close
157
Open Price
157
Volume
11
Today Low / High
155.4 / 157
52 WK Low / High
82.15 / 168
Range
148 - 163
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 155.4, reflecting a change of -1.6 (-1.01911%). The expected target range on the BSE is 148 - 163. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Centenial Surgical Suture Limited Graph
Centenial Surgical Suture Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Centenial Surgical Suture Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 155.40, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 155.40 | 156.95 | 141.26 - 172.65 |
| 158.51 | 126.81 - 190.21 | ||
| 160.06 | 112.04 - 208.08 | ||
| Bearish Scenario | 155.40 | 153.85 | 138.46 - 169.23 |
| 152.29 | 121.83 - 182.75 | ||
| 150.74 | 105.52 - 195.96 |
Overview of Centenial Surgical Suture Limited
ISIN
INE405H01018
Industry
Medical - Specialties
Vol.Avg
224
Market Cap
558,189,900
Last Dividend
0
Official Website
IPO Date
2007-12-18
DCF Diff
118.43
DCF
35
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 53.52 Cr | 33.34 Cr | 20.18 Cr | 0.3770 | 0.00 Cr | 0.00 Cr | 2.01 Cr | -1.46 Cr | -3.97 | 6.38 Cr | -0.0274 |
| 2024-03-31 | 51.19 Cr | 17.30 Cr | 33.89 Cr | 0.6621 | 0.00 Cr | 0.56 Cr | 3.76 Cr | 1.13 Cr | 3.11 | 5.13 Cr | 0.0222 |
| 2023-03-31 | 52.66 Cr | 20.23 Cr | 32.43 Cr | 0.6158 | 0.00 Cr | 0.60 Cr | 3.10 Cr | 1.00 Cr | 2.43 | 4.53 Cr | 0.0190 |
| 2022-03-31 | 44.43 Cr | 19.80 Cr | 24.62 Cr | 0.5542 | 0.00 Cr | 0.57 Cr | 2.96 Cr | 0.63 Cr | 1.72 | 4.53 Cr | 0.0141 |
| 2021-03-31 | 36.93 Cr | 10.59 Cr | 26.35 Cr | 0.7133 | 0.00 Cr | 0.67 Cr | 3.56 Cr | 0.96 Cr | 2.64 | 5.20 Cr | 0.0260 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.22 Cr | 84.58 Cr | 53.83 Cr | 30.7549 Cr | 12.26 Cr | 12.04 Cr | 43.48 Cr | 19.98 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 31.8296 Cr |
| 2024-03-31 | 0.68 Cr | 79.15 Cr | 46.93 Cr | 32.2184 Cr | 27.60 Cr | 26.92 Cr | 42.52 Cr | 12.77 Cr | 0.00 Cr | 1.66 Cr | 0.00 Cr | 32.8499 Cr |
| 2023-03-31 | 0.33 Cr | 66.40 Cr | 35.32 Cr | 31.0840 Cr | 14.98 Cr | 14.65 Cr | 37.24 Cr | 6.46 Cr | 3.33 Cr | 1.66 Cr | 0.00 Cr | 29.0738 Cr |
| 2022-03-31 | 0.26 Cr | 61.34 Cr | 31.14 Cr | 30.1982 Cr | 14.91 Cr | 14.66 Cr | 32.26 Cr | 7.60 Cr | 2.85 Cr | 1.66 Cr | 0.00 Cr | 24.2043 Cr |
| 2021-03-31 | 0.54 Cr | 70.05 Cr | 40.47 Cr | 29.5711 Cr | 12.82 Cr | 12.29 Cr | 36.23 Cr | 8.97 Cr | 7.66 Cr | 1.92 Cr | 0.00 Cr | 31.5016 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 13.3286 Cr | -11.6073 Cr | -2.1864 Cr | 1.8595 Cr | 0.0000 Cr | 0.2195 Cr | -11.4691 Cr | -1.4637 Cr | -2.1864 Cr | 0.0000 Cr | -0.9659 Cr |
| 2024-03-31 | 3.7458 Cr | -7.9194 Cr | 4.5282 Cr | -3.9502 Cr | 0.3546 Cr | 0.6846 Cr | -7.6960 Cr | 1.1344 Cr | 4.5283 Cr | 0.0000 Cr | -5.2728 Cr |
| 2023-03-31 | 1.2953 Cr | -0.1757 Cr | -1.0462 Cr | 1.1342 Cr | 0.0735 Cr | 0.3300 Cr | -0.1611 Cr | 1.4629 Cr | -1.0462 Cr | 0.0000 Cr | -4.9781 Cr |
| 2022-03-31 | 4.7509 Cr | -0.1661 Cr | -4.8669 Cr | 4.5939 Cr | -0.2821 Cr | 0.2565 Cr | -0.1570 Cr | 1.0745 Cr | -2.9749 Cr | 0.0000 Cr | 3.9676 Cr |
| 2021-03-31 | 1.9684 Cr | -0.8867 Cr | -1.2660 Cr | 1.1300 Cr | -0.1843 Cr | 0.5386 Cr | -0.8384 Cr | 1.5299 Cr | 0.7508 Cr | 0.0000 Cr | -4.0337 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 13.31 Cr | 7.85 Cr | 5.46 Cr | 0.4101 | 0.80 Cr | -1.18 Cr | -3.21 | 2.12 Cr | -0.0889 |
| 2024-12-31 | 12.20 Cr | 3.24 Cr | 8.95 Cr | 0.7341 | -0.36 Cr | -0.85 Cr | -2.30 | 0.76 Cr | -0.0695 |
| 2024-09-30 | 14.27 Cr | 5.62 Cr | 8.66 Cr | 0.6064 | 0.63 Cr | 0.13 Cr | 0.35 | 1.79 Cr | 0.0089 |
| 2024-06-30 | 13.74 Cr | 8.44 Cr | 5.29 Cr | 0.3853 | 0.93 Cr | 0.30 Cr | 0.82 | 1.72 Cr | 0.0217 |
| 2024-03-31 | 12.05 Cr | 7.08 Cr | 4.97 Cr | 0.4126 | 1.07 Cr | 0.19 Cr | 0.52 | 1.54 Cr | 0.0158 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.22 Cr | 0.00 Cr | 0.22 Cr | 18.40 Cr | 43.48 Cr | 62.96 Cr | 19.98 Cr | 84.58 Cr | 53.83 Cr |
| 2024-09-30 | 1.15 Cr | 0.00 Cr | 1.15 Cr | 0.00 Cr | 42.14 Cr | 65.23 Cr | 20.76 Cr | 87.07 Cr | 54.43 Cr |
| 2024-03-31 | 0.68 Cr | 0.47 Cr | 0.68 Cr | 21.95 Cr | 42.52 Cr | 65.32 Cr | 12.77 Cr | 79.15 Cr | 46.93 Cr |
| 2023-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 0.47 Cr | 0.00 Cr | 0.47 Cr | 20.87 Cr | 40.23 Cr | 62.75 Cr | 6.26 Cr | 69.63 Cr | 38.01 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | 0.31 Cr | 0.66 Cr | 0.00 Cr | 0.00 Cr | 0.66 Cr | 1.13 Cr | 0.47 Cr | 0.00 Cr | 0.66 Cr |
| 2023-09-30 | 0.24 Cr | 0.24 Cr | 0.00 Cr | 0.00 Cr | 0.24 Cr | 0.47 Cr | 0.23 Cr | 0.00 Cr | 0.24 Cr |
| 2023-06-30 | 0.29 Cr | 0.29 Cr | 0.00 Cr | 0.00 Cr | -0.04 Cr | 0.29 Cr | 0.33 Cr | 0.00 Cr | 0.29 Cr |
| 2023-03-31 | 0.14 Cr | 0.14 Cr | 0.00 Cr | 0.00 Cr | 0.14 Cr | 0.33 Cr | 0.19 Cr | 0.00 Cr | 0.14 Cr |
| 2022-12-31 | 0.28 Cr | 0.28 Cr | 0.00 Cr | 0.00 Cr | 0.28 Cr | 0.28 Cr | 0.00 Cr | 0.00 Cr | 0.28 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Specialties
No stocks found in this industry.
Key Executives
Gender: male
Year Born: 1961
Gender: Not Specified
Year Born:
Gender: female
Year Born:
Gender: female
Year Born: 1961
Gender: female
Year Born:
Gender: male
Year Born: 1968
FAQs about Centenial Surgical Suture Limited
The CEO is Vijay Kalidas Majrekar.
The current price is ₹153.00.
The range is ₹82.15-168.
The market capitalization is ₹55.82 crores.
The P/E ratio is -34.73.
The company operates in the Healthcare sector.
Overview of Centenial Surgical Suture Limited (ISIN: INE405H01018) is a leading Medical - Specialties in India. With a market capitalization of ₹55.82 crores and an average daily volume of 224 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.